Full-dose GLP-1 therapy can sometimes be associated with low energy during early use
How Long to Wait After Stopping GLP-1 Medications Before you try to get pregnant again, you need to give these drugs time to leave your body
Conclusion: The outlook for state Medicaid coverage of GLP-1 AOMs While 13 state Medicaid programs covered at least one GLP-1 approved for weight management as of August 2024, states subsequently reversed course: California, New Hampshire, Pennsylvania, and South Carolina recently withdrew coverage
Individual responses vary, which is why baseline colitis assessment and close monitoring during the first 48 weeks of treatment are essential
Lectin avoidance, the dietary approach Clarkson referenced from Gundry's work, has no published randomized trial data supporting meaningful weight-loss efficacy independent of overall caloric restriction
In January 2026, the FDA issued a warning letter to a 503A compounding pharmacy specifically for GLP-1 product violations involving insanitary conditions and strength, quality, and purity noncompliance
